Dear John,

This week, we released our July issue focusing on health spending, maternal care, rural hospitals, and more.

Today's Featured Articles

New Cancer Drug Approvals: Less Than Half Of Important Clinical Trial Uncertainties Reported By The FDA To Clinicians, 2019–22

Avi Cherla et al.

Drug Coverage Policies And Clinical Guidelines Alignment: Most Coverage Decisions Include Additional Restrictions

Julia A. Rucker et al.

Modernizing The Medicare Physician Fee Schedule, Part 1: The Role Of A Technical Expert Panel

Robert A. Berenson

Modernizing The Medicare Physician Fee Schedule, Part 2: Medicare Economic Index Updates

Stephen Zuckerman and Robert A. Berenson

Health Insurance Affordability: Balancing Premiums And Out-Of-Pocket Costs

Cori Uccello

More on Clinical Trials

First-In-Class Drugs Experienced Different Regulatory Treatment In The US And Europe

Jihye Han and Aaron S. Kesselheim (March 2025)

Towards A National Action Plan To Improve Representation In Clinical Trials

Esther Krofah et al. (November 2024)

Building A Resilient, Sustainable, And Representative Clinical Trials Enterprise

Carolyn Shore et al. (January 2024)

340B w/ Sayeh Nikpay

Join Health Affairs on August 20 for an exclusive Insider virtual event breaking down the 340B program with Sayeh Nikpay.

Nikpay joins Health Affairs’ Jessica Bylander to get Insiders up to speed on 340B, what’s new with the program’s policy considerations, how that manifests itself beyond the halls of Congress, and what is on the table for new policy and/or implementation arrangements.

Become an Insider to get access to exclusive events, our trend reports, and monthly newsletters.